Navigation Links
I Am a Muslim With Moderate Views, Haneef Tells Australian Police

India is seeking consular access to Mohammed Haneef, currently detained in Australia, in connection with the failed Glasgow bombing.

On Tuesday the Indian External Affairs Ministry summoned Australia's high commissioner, John McCarthy, to express its concern over the treatment of Haneef.

"The External Affairs Ministry has expressed its concern to the Australian Government that Dr Mohamed Haneef should be treated fairly and justly under Australian law," said a ministry spokesman.


'"/>




Page: 1

Related medicine news :

1. Family planning is insisted upon Muslims by Shia cleric
2. AIDS bias successfully overcome by Indian Muslims in South Africa
3. Muslim Leaders’ Help Sought To Discourage Smokin
4. Muslims in Malaysia Banned from Using Botox
5. Muslim Leaders Urge Community to Join Anti-Polio Drive
6. Sexual Harassment on the Rise in Aligarh Muslim University
7. Burka Style Inter-faith Gowns For Muslim Patients In UK
8. Veils Banned to Muslim medicos in Birmingham Hospital
9. Muslim Clerics to Join Hands to Eradicate Polio
10. Separate and Specific Health Care Facilities for Muslims
11. Madhya Pradesh Begins Surya Namaskar Amid Muslim Opposition
Post Your Comments:
Breaking Medicine Technology:Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society 52505 1Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society 52505 2President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 1President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 2President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 3St Johns Hospital Acquires Latest Technology in Robotic Assisted Surgery 13163 1St Johns Hospital Acquires Latest Technology in Robotic Assisted Surgery 13163 2